Research articlePublished 12 Jan 2021
Ageratum Conyzoides L. Extract Inhibits 5α-Reductase Gene Expression and Prostaglandin D2 Release in Human Hair Dermal Papilla Cells and Improves Symptoms of Hair Loss in Otherwise Healthy Males and Females in an Open Label Pilot Study
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Hair loss is a debilitating condition often encountered by older adults. Common hair loss treatments such as Minoxidil and Finasteride are associated with potentially severe adverse effects. Ageratum conyzoides L., an annual herb shown to inhibit pathways associated with hair-loss is a potential safe and effective alternative treatment for hair loss. Objective: A pilot, open-label, randomized, parallel and in vitro study assessed the efficacy and safety of an Ageratum conyzoides formulation on hair loss. Methods: 28 otherwise healthy males and females over 18 years of age exhibiting pattern baldness received either a 0.5% or 1% strength A. conyzoides gel formulation to be applied topically twice per day for 8 weeks. Hair growth as measured by temporal recession distance and participants' quality of life was assessed by the Hair Distress Questionnaire. The effect of an A. conyzoides extract on gene expression of 5α-reductase and release of prostaglandin D2 (PGD2) in human Hair Dermal Papilla Cells (HHDPC) was also assessed to determine mechanisms of action. Results: Temporal recession in men reduced from 9.1 cm to 8.6 cm in the 1% group and from 8.6 to 7.5 cm in the 0.5% group. The normal distance in men without recession is between 6-6.5 cm. Among males, hair distress questionnaire scores fell by 6 and 3.6 points from baseline for the 0.5% and 1% product respectively. In the 1% treatment group, 64% of men and 100% of women reported an improvement in their hair loss symptoms. Over 65% of participants indicated a significant improvement in their hair related quality of life (p<0.05). In the in vitro study, the A. conyzoides extract significantly inhibited PGD2 release and 5 α-reductase type 1 expression in HHDPC. Conclusion: These results indicate that A. conyzoides may be an effective treatment option for facilitating hair growth and inhibiting hair loss. Abbreviations: AGA, Androgenetic Alopecia; PGDS, Prostaglandin D synthase; PGD2, Prostaglandin D2; HHDPC, Human Hair Dermal Papilla Cells; DHT, Dihydrotestosterone.
Subjects
DermatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cosmetology & Trichology
- SubjectDermatology
- BylineArticles whose byline prints “Paul Clayton”
- BylineArticles whose byline prints “Ruchitha Venkatesh”
- BylineArticles whose byline prints “Nathasha Bogoda”
- BylineArticles whose byline prints “Silma Subah”
